Dear John,

Health Affairs Scholar is excited to announce a call for papers on three topics: Global Aging, Intersections of Social Policies and Health and Policy Options for the 340B Drug Discount program.

For more information on the topics and how to submit, visit the Health Affairs Scholar website.

Today's Featured Articles

Cost-Effectiveness And Health Impact Of Increasing Emergency Department Pediatric Readiness In The US

Christopher Weyant et al.

Ethics And Health Systems Change: Introduction

M Gregg Bloche

How State Policy Makers Can Tackle Medical Debt: Lessons From North Carolina

Kody H. Kinsley

More on Cost-effectiveness

The Risk Of Perpetuating Health Disparities Through Cost-Effectiveness Analyses

Sanjay Basu et al. (August 2024)

Controversy Over Using Quality-Adjusted Life-Years In Cost-Effectiveness Analyses: A Systematic Literature Review

Leah Z. Rand and Aaron S. Kesselheim (September 2021)

The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness

Jeroen Luyten and Philippe Beutels (February 2016)

Community & State is the business segment of UnitedHealthcare that provides health care coverage for the economically disadvantaged, the medically underserved and those without the benefit of employer-funded health plans. These state-based health plans meet local needs, while leveraging the national resources of UnitedHealthcare.

Medicare Advantage Star Ratings Continue to Fade but Market Marches On Into 2025

Health Affairs' Jeff Byers welcomes Senior Editor Michael Gerber back to the program to discuss Medicare open enrollment, the newly-announced 2025 Medicare Advantage and Part D Star Ratings, and how large insurance companies may be scaling back Medicare Advantage product offerings.

Election Day is on the horizon and Health Affairs has been collecting articles that we've published over the years to reflect on evidence and analysis on key issues that impact the health policy sector.

Our Election 2024 Collection features journal and Forefront articles, health policy briefs, podcasts, and theme issues on topics including drug costs, reproductive health, the Affordable Care Act, and more.

Purchase the collection to access all paywalled articles for the low price of $39.95.

“Low- And Middle-Income Countries Experienced Delays Accessing New Essential Medicines”

Join Health Affairs October 21 for a virtual event examining the timing of new drug launches in low-, middle-, and high-income markets from 1982 to 2024.

This event is exclusive to Health Affairs Insiders.